Retatrutide in Australia — research guide, purity and pricing

Retatrutide is a single-chain synthetic peptide (development code LY3437943) designed to act at three incretin and metabolic receptors — GLP-1, GIP and the glucagon receptor — rather than one. That multi-receptor design is the reason it is studied separately from single- and dual-agonist peptides.

It is an investigational compound. It has not been registered by the TGA and is supplied here only as a laboratory reference material for in-vitro work.

Peer-reviewed work on Retatrutide sits in the metabolic research literature and examines receptor binding and signalling behaviour across the three target receptors, plus metabolic endpoints in clinical trial settings run by the compound's developer.

We do not summarise trial outcomes or reproduce endpoint figures here, and we publish no dosing protocols. Search the primary literature directly using the reference links below and read the papers in full.

Semaglutide is a single GLP-1 receptor agonist. Tirzepatide is a dual GLP-1/GIP agonist. Retatrutide adds glucagon-receptor activity on top of both, which is why it is described as a triple agonist in the literature.

For comparative in-vitro work, researchers commonly run the three side by side on the same assay and lot-match each vial to its Certificate of Analysis so receptor-selectivity data is traceable. All three are stocked in our metabolic range.

Lyophilised material is typically reconstituted with bacteriostatic water added slowly down the vial wall, then swirled rather than shaken to avoid shearing the peptide. A 10mg vial reconstituted with 2mL yields 5mg/mL.

Record the reconstitution volume and date against the lot number so concentration stays traceable in your notes. Bacteriostatic water and 31G insulin syringes ship in the same cold-chain parcel as your vials.

Lyophilised (freeze-dried) peptides are shipped cold-chain packed and are typically stored at -20°C for long-term storage, or 2-8°C for short periods before reconstitution.

Once reconstituted with bacteriostatic water, vials are generally refrigerated at 2-8°C and protected from light and repeated freeze-thaw cycles.

Every Aussie Peptides vial carries a lot number that maps to a batch Certificate of Analysis, so purity and identity can be recorded alongside your experimental data.

Materials on this site are supplied strictly for in-vitro laboratory research. They are not therapeutic goods, are not approved by the TGA for human use, and are not supplied for human or veterinary consumption.

Purchasers must be 18 or over and are responsible for handling, storing and disposing of research materials in line with their institution's requirements and applicable Australian law.

Nothing on this page is medical advice, a dosing protocol, or a claim of therapeutic benefit. It summarises what the published research literature investigates.